Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 531 (Romiplostim) in ITP Prior to Splenectomy
NCT00102336Phase 3Completed
- Sponsor
- Amgen
- Start
- Apr 2005
- Primary completion
- Dec 2006
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of romiplostim in immune thrombocytopenic purpura (ITP), sponsored by Amgen. Started Apr 2005; status: completed.
02
Drugs
romiplostim
03
Conditions
immune thrombocytopenic purpura (ITP)
Beyond the preview
Go deeper on NCT00102336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102336.